Viral Oncogenesis Biomarkers in Diagnostics: From Tumor Viruses to Precision Cancer Medicine
DOI:
https://doi.org/10.70749/ijbr.v2i02.402Keywords:
Oncogenic Viruses, Biomarkers, Carcinogenesis, Viral Oncogenesis, Cancer Diagnosis, Prevention StrategiesAbstract
This comprehensive exploration delves into the intricate realm of oncogenic viruses, spanning the Epstein-Barr virus, Hepatitis B virus, Hepatitis C virus, Kaposi's sarcoma herpesvirus, and Human T-cell lymphotropic virus type 1. An in-depth examination of specific components, including the functions of TAX and HPZ in HTLV-1, sheds light on the sophisticated mechanisms governing viral-induced oncogenesis. The discourse extends to the Human Papillomavirus, encompassing both Alpha and Beta types, elucidating their distinct roles in cancer pathogenesis. Transitioning to biomarkers, the discourse investigates microRNAs as potential diagnostic indicators in EBV-associated diseases. Serum biomarkers indicative of hepatocyte carcinoma resulting from HBV and HCV infections are scrutinized, highlighting the crucial role of biomarkers in early detection and prognosis. Tumor biomarkers and their implications in cancer diagnosis within the context of KSHV are explored. The discourse concludes with a focus on biomarkers in cervical cancer prevention linked to HPV, emphasizing their significance in screening and monitoring protocols.
Downloads
References
Arbyn, M., Ronco, G., Meijer, C., & Naucler, P. (2009). Trials comparing cytology with human papillomavirus screening. The Lancet Oncology, 10(10), 935-936. https://doi.org/10.1016/s1470-2045(09)70296-7
Arbyn, M., Sasieni, P., Meijer, C. J., Clavel, C., Koliopoulos, G., & Dillner, J. (2006). Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses. Vaccine, 24, S78-S89. https://doi.org/10.1016/j.vaccine.2006.05.117
Baak, J. P., Kruse, A., Robboy, S. J., Janssen, E. A., Van Diermen, B., & Skaland, I. (2006). Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. Journal of Clinical Pathology, 59(10), 1017-1028. https://doi.org/10.1136/jcp.2005.027839
Barth, S., Meister, G., & Grässer, F. A. (2011). EBV-encoded miRNAs. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1809(11-12), 631-640. https://doi.org/10.1016/j.bbagrm.2011.05.010
Beer, D. G., Kardia, S. L., Huang, C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., Lizyness, M. L., Kuick, R., Hayasaka, S., Taylor, J. M., Iannettoni, M. D., Orringer, M. B., & Hanash, S. (2002). Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Medicine, 8(8), 816-824. https://doi.org/10.1038/nm733
Bergvall, M., Melendy, T., & Archambault, J. (2013). The E1 proteins. Virology, 445(1-2), 35-56. https://doi.org/10.1016/j.virol.2013.07.020
Best, M., Sol, N., Kooi, I., Tannous, J., Westerman, B., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., Ylstra, B., Ameziane, N., Dorsman, J., Smit, E., Verheul, H., Noske, D., Reijneveld, J., Nilsson, R., Tannous, B., … Wurdinger, T. (2015). RNA-SEQ of tumor-educated platelets enables blood-based pan-cancer, Multiclass, and molecular pathway cancer diagnostics. Cancer Cell, 28(5), 666-676. https://doi.org/10.1016/j.ccell.2015.09.018
Branca, M., Giorgi, C., Santini, D., Bonito, L. D., Ciotti, M., Costa, S., Benedetto, A., Casolati, E. A., Favalli, C., Paba, P., Di Bonito, P., Mariani, L., Syrjänen, S., Bonifacio, D., Accardi, L., Zanconati, F., Syrjänen, K., & HPV-Pathogen ISS Study Group, O. B. (2005). Survivin as a marker of cervical Intraepithelial Neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer. American Journal of Clinical Pathology, 124(1), 113-121. https://doi.org/10.1309/l8bw-f431-wu9a-c8fj
Brase, J. C., Wuttig, D., Kuner, R., & Sültmann, H. (2010). Serum microRNAs as non-invasive biomarkers for cancer. Molecular Cancer, 9(1), 306. https://doi.org/10.1186/1476-4598-9-306
Brunnström, H., Johansson, L., Jirström, K., Jönsson, M., Jönsson, P., & Planck, M. (2013). Immunohistochemistry in the differential diagnostics of primary lung cancer. American Journal of Clinical Pathology, 140(1), 37-46. https://doi.org/10.1309/ajcp50rdxscsbtbo
Campbell, J. D., Alexandrov, A., Kim, J., Wala, J., Berger, A. H., Pedamallu, C. S., Shukla, S. A., Guo, G., Brooks, A. N., Murray, B. A., Imielinski, M., Hu, X., Ling, S., Akbani, R., Rosenberg, M., Cibulskis, C., Ramachandran, A., Collisson, E. A., & Meyerson, M. (2016). Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas. Nature Genetics, 48(6), 607-616. https://doi.org/10.1038/ng.3564
Campbell, T. B., Borok, M., Gwanzura, L., MaWhinney, S., White, I. E., Ndemera, B., Gudza, I., Fitzpatrick, L., & Schooley, R. T. (2000). Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage. AIDS, 14(14), 2109-2116. https://doi.org/10.1097/00002030-200009290-00006
Cao, W., Chen, H., Yu, Y., Li, N., & Chen, W. (2021). Changing profiles of cancer burden worldwide and in China: A secondary analysis of the global cancer statistics 2020. Chinese Medical Journal, 134(7), 783-791. https://doi.org/10.1097/cm9.0000000000001474
Carbone, A. (2002). AIDS-related non-Hodgkin's lymphomas: From pathology and molecular pathogenesis to treatment. Human Pathology, 33(4), 392-404. https://doi.org/10.1053/hupa.2002.124723
Casper, C., Corey, L., Cohen, J. I., Damania, B., Gershon, A. A., Kaslow, D. C., Krug, L. T., Martin, J., Mbulaiteye, S. M., Mocarski, E. S., Moore, P. S., Ogembo, J. G., Phipps, W., Whitby, D., & Wood, C. (2022). KSHV (HHV8) vaccine: Promises and potential pitfalls for a new anti-cancer vaccine. npj Vaccines, 7(1). https://doi.org/10.1038/s41541-022-00535-4
Castellsagué, X., Díaz, M., De Sanjosé, S., Muñoz, N., Herrero, R., Franceschi, S., Peeling, R. W., Ashley, R., Smith, J. S., Snijders, P. J., Meijer, C. J., & Bosch, F. X. (2006). Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: Implications for screening and prevention. JNCI: Journal of the National Cancer Institute, 98(5), 303-315. https://doi.org/10.1093/jnci/djj067
Castle, A. L. (2006). Metabolomics standards workshop and the development of international standards for reporting metabolomics experimental results. Briefings in Bioinformatics, 7(2), 159-165. https://doi.org/10.1093/bib/bbl008
Cattani, P., Zannoni, G. F., Ricci, C., D'Onghia, S., Trivellizzi, I. N., Di Franco, A., Vellone, V. G., Durante, M., Fadda, G., Scambia, G., Capelli, G., & De Vincenzo, R. (2009). Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. Journal of Clinical Microbiology, 47(12), 3895-3901. https://doi.org/10.1128/jcm.01275-09
Cesarman, E. (2011). Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Letters, 305(2), 163-174. https://doi.org/10.1016/j.canlet.2011.03.003
Chang, H., Dittmer, D. P., Chul, S., Hong, Y., & Jung, J. U. (2005). Role of notch signal transduction in Kaposi's sarcoma-associated Herpesvirus gene expression. Journal of Virology, 79(22), 14371-14382. https://doi.org/10.1128/jvi.79.22.14371-14382.2005
Chayvialle, J., & Ganguli, P. (1973). Radioimmunoassay of Alpha-fetoprotein in human plasma. The Lancet, 301(7816), 1355-1357. https://doi.org/10.1016/s0140-6736(73)91676-0
Chen, L., Liu, D., Zhang, Y., Zhang, H., & Cheng, H. (2015). The autophagy molecule Beclin 1 maintains persistent activity of NF-κb and Stat3 in HTLV-1-transformed T lymphocytes. Biochemical and Biophysical Research Communications, 465(4), 739-745. https://doi.org/10.1016/j.bbrc.2015.08.070
Chen, Z., Lin, L., Wu, C., Li, C., Xu, R., & Sun, Y. (2021). Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine. Cancer Communications, 41(11), 1100-1115. https://doi.org/10.1002/cac2.12215
Chisari, F. V. (2000). Viruses, immunity, and cancer: Lessons from hepatitis B. The American Journal of Pathology, 156(4), 1117-1132. https://doi.org/10.1016/s0002-9440(10)64980-2
Chisari, F. V., Pinkert, C. A., Milich, D. R., Filippi, P., McLachlan, A., Palmiter, R. D., & Brinster, R. L. (1985). A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science, 230(4730), 1157-1160. https://doi.org/10.1126/science.3865369
Cohen, J. I. (2000). Epstein–Barr virus infection. New England Journal of Medicine, 343(7), 481-492. https://doi.org/10.1056/nejm200008173430707
Croft, N. P., Shannon-Lowe, C., Bell, A. I., Horst, D., Kremmer, E., Ressing, M. E., Wiertz, E. J., Middeldorp, J. M., Rowe, M., Rickinson, A. B., & Hislop, A. D. (2009). Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus Lytic cycle. PLoS Pathogens, 5(6), e1000490. https://doi.org/10.1371/journal.ppat.1000490
Cui, X., & Snapper, C. M. (2021). Epstein Barr virus: Development of vaccines and immune cell therapy for EBV-associated diseases. Frontiers in Immunology, 12. https://doi.org/10.3389/fimmu.2021.734471
Cuzick, J., Arbyn, M., Sankaranarayanan, R., Tsu, V., Ronco, G., Mayrand, M., Dillner, J., & Meijer, C. J. (2008). Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine, 26, K29-K41. https://doi.org/10.1016/j.vaccine.2008.06.019
Delgado, T., Carroll, P. A., Punjabi, A. S., Margineantu, D., Hockenbery, D. M., & Lagunoff, M. (2010). Induction of the Warburg effect by Kaposi's sarcoma herpesvirus is required for the maintenance of latently infected endothelial cells. Proceedings of the National Academy of Sciences, 107(23), 10696-10701. https://doi.org/10.1073/pnas.1004882107
Della Bella, S., Taddeo, A., Calabrò, M. L., Brambilla, L., Bellinvia, M., Bergamo, E., Clerici, M., & Villa, M. L. (2008). Peripheral blood endothelial progenitors as potential reservoirs of Kaposi's sarcoma-associated Herpesvirus. PLoS ONE, 3(1), e1520. https://doi.org/10.1371/journal.pone.0001520
Dillner, J., Rebolj, M., Birembaut, P., Petry, K., Szarewski, A., Munk, C., De Sanjose, S., Naucler, P., Lloveras, B., Kjaer, S., Cuzick, J., Van Ballegooijen, M., Clavel, C., & Iftner, T. (2008). Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: Joint European cohort study. BMJ, 337(oct13 1), a1754-a1754. https://doi.org/10.1136/bmj.a1754
DiMaio, D., & Petti, L. M. (2013). The E5 proteins. Virology, 445(1-2), 99-114. https://doi.org/10.1016/j.virol.2013.05.006
Doorbar, J. (2007). Papillomavirus life cycle organization and biomarker selection. Disease Markers, 23(4), 297-313. https://doi.org/10.1155/2007/613150
Doorbar, J. (2013). The E4 protein; structure, function and patterns of expression. Virology, 445(1-2), 80-98. https://doi.org/10.1016/j.virol.2013.07.008
Doorbar, J., Egawa, N., Griffin, H., Kranjec, C., & Murakami, I. (2015). Human papillomavirus molecular biology and disease association. Reviews in Medical Virology, 25(S1), 2-23. https://doi.org/10.1002/rmv.1822
Dupin, N., Fisher, C., Kellam, P., Ariad, S., Tulliez, M., Franck, N., Van Marck, E., Salmon, D., Gorin, I., Escande, J., Weiss, R. A., Alitalo, K., & Boshoff, C. (1999). Distribution of human herpesvirus-8 latently infected cells in Kaposi’s sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma. Proceedings of the National Academy of Sciences, 96(8), 4546-4551. https://doi.org/10.1073/pnas.96.8.4546
El-Serag, H. B. (2004). Hepatocellular carcinoma: Recent trends in the United States. Gastroenterology, 127(5), S27-S34. https://doi.org/10.1053/j.gastro.2004.09.013
Fabbri, M., Paone, A., Calore, F., Galli, R., Gaudio, E., Santhanam, R., Lovat, F., Fadda, P., Mao, C., Nuovo, G. J., Zanesi, N., Crawford, M., Ozer, G. H., Wernicke, D., Alder, H., Caligiuri, M. A., Nana-Sinkam, P., Perrotti, D., & Croce, C. M. (2012). MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proceedings of the National Academy of Sciences, 109(31), E2110–E2116. https://doi.org/10.1073/pnas.1209414109
Ferracin, M., Veronese, A., & Negrini, M. (2010). Micromarkers: MiRNAs in cancer diagnosis and prognosis. Expert Review of Molecular Diagnostics, 10(3), 297-308. https://doi.org/10.1586/erm.10.11
Food, U. S. (2015). Drug Administration FDA Approves Keytruda for Advanced Non-Small Cell Lung Cancer.
Füzéry, A. K., Levin, J., Chan, M. M., & Chan, D. W. (2013). Translation of proteomic biomarkers into FDA approved cancer diagnostics: Issues and challenges. Clinical Proteomics, 10(1). https://doi.org/10.1186/1559-0275-10-13
Galloway, D. A., & Laimins, L. A. (2015). Human papillomaviruses: Shared and distinct pathways for pathogenesis. Current Opinion in Virology, 14, 87-92. https://doi.org/10.1016/j.coviro.2015.09.001
Gerlinger, M., et al. (2012). "Intratumor heterogeneity and branched evolution revealed by multiregion sequencing." New England Journal of Medicine 366(10): 883-892.
Gourzones, C., Gelin, A., Bombik, I., Klibi, J., Vérillaud, B., Guigay, J., Lang, P., Témam, S., Schneider, V., Amiel, C., Baconnais, S., Jimenez, A., & Busson, P. (2010). Extra-cellular release and blood diffusion of BART viral micro-RNAs produced by EBV-infected nasopharyngeal carcinoma cells. Virology Journal, 7(1). https://doi.org/10.1186/1743-422x-7-271
Govindan, R., Ding, L., Griffith, M., Subramanian, J., Dees, N., Kanchi, K., Maher, C., Fulton, R., Fulton, L., Wallis, J., Chen, K., Walker, J., McDonald, S., Bose, R., Ornitz, D., Xiong, D., You, M., Dooling, D., Watson, M., … Wilson, R. (2012). Genomic landscape of non-small cell lung cancer in smokers and never-smokers. Cell, 150(6), 1121-1134. https://doi.org/10.1016/j.cell.2012.08.024
Green, P. L., & Chen, I. S. (1990). Regulation of human T cell leukemia virus expression 1. The FASEB Journal, 4(2), 169-175. https://doi.org/10.1096/fasebj.4.2.2404818
Hagiya, K., Yasunaga, J., Satou, Y., Ohshima, K., & Matsuoka, M. (2011). ATF3, an HTLV-1 bZip factor binding protein, promotes proliferation of adult T-cell leukemia cells. Retrovirology, 8(1). https://doi.org/10.1186/1742-4690-8-19
Halloush, R. A., Akpolat, I., “Jim” Zhai, Q., Schwartz, M. R., & Mody, D. R. (2008). Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material. Cancer, 114(6), 474-480. https://doi.org/10.1002/cncr.23951
Hanahan, D., & Weinberg, R. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646-674. https://doi.org/10.1016/j.cell.2011.02.013
Hanash, S. M., Baik, C. S., & Kallioniemi, O. (2011). Emerging molecular biomarkers—blood-based strategies to detect and monitor cancer. Nature Reviews Clinical Oncology, 8(3), 142-150. https://doi.org/10.1038/nrclinonc.2010.220
Hasham, K., Ahmed, N., & Zeshan, B. (2020). Circulating microRNAs in oncogenic viral infections: Potential diagnostic biomarkers. SN Applied Sciences, 2(3). https://doi.org/10.1007/s42452-020-2251-0
Hassan, M. M., Hwang, L., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002). Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology, 36(5), 1206-1213. https://doi.org/10.1053/jhep.2002.36780
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996). Methylation-specific PCR: A novel PCR assay for methylation status of CPG islands. Proceedings of the National Academy of Sciences, 93(18), 9821-9826. https://doi.org/10.1073/pnas.93.18.9821
Hiam-Galvez, K. J., Allen, B. M., & Spitzer, M. H. (2021). Systemic immunity in cancer. Nature Reviews Cancer, 21(6), 345-359. https://doi.org/10.1038/s41568-021-00347-z
Hoppe-Seyler, K., Bossler, F., Braun, J. A., Herrmann, A. L., & Hoppe-Seyler, F. (2018). The hpv e6/E7 oncogenes: Key factors for viral carcinogenesis and therapeutic targets. Trends in Microbiology, 26(2), 158-168. https://doi.org/10.1016/j.tim.2017.07.007
Houghton, M. (1991). Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology, 14(2), 381-388. https://doi.org/10.1016/0270-9139(91)91430-9
Howley, P. M., & Pfister, H. J. (2015). Beta genus papillomaviruses and skin cancer. Virology, 479-480, 290-296. https://doi.org/10.1016/j.virol.2015.02.004
IARC, A. (2012). "Review of Human Carcinogens." Part F. Chemical Agents and Related Occupations 100.
Iizasa, H., Nanbo, A., Nishikawa, J., Jinushi, M., & Yoshiyama, H. (2012). Epstein-Barr virus (ebv)-associated gastric carcinoma. Viruses, 4(12), 3420-3439. https://doi.org/10.3390/v4123420
KAO, J. (2002). Hepatitis B viral genotypes: Clinical relevance and molecular characteristics. Journal of Gastroenterology and Hepatology, 17(6), 643-650. https://doi.org/10.1046/j.1440-1746.2002.02737.x
Katki, H. A., Kinney, W. K., Fetterman, B., Lorey, T., Poitras, N. E., Cheung, L., Demuth, F., Schiffman, M., Wacholder, S., & Castle, P. E. (2011). Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: A population-based study in routine clinical practice. The Lancet Oncology, 12(7), 663-672. https://doi.org/10.1016/s1470-2045(11)70145-0
Kawa, K., Sawada, A., Sato, M., Okamura, T., Sakata, N., Kondo, O., Kimoto, T., Yamada, K., Tokimasa, S., Yasui, M., & Inoue, M. (2010). Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplantation, 46(1), 77-83. https://doi.org/10.1038/bmt.2010.122
Kikuchi, T., Daigo, Y., Katagiri, T., Tsunoda, T., Okada, K., Kakiuchi, S., Zembutsu, H., Furukawa, Y., Kawamura, M., Kobayashi, K., Imai, K., & Nakamura, Y. (2003). Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene, 22(14), 2192-2205. https://doi.org/10.1038/sj.onc.1206288
Kim, Y. C., & Guan, K. (2015). MTOR: A pharmacologic target for autophagy regulation. Journal of Clinical Investigation, 125(1), 25-32. https://doi.org/10.1172/jci73939
Kim, Y. J., Sertamo, K., Pierrard, M., Mesmin, C., Kim, S. Y., Schlesser, M., Berchem, G., & Domon, B. (2015). Verification of the biomarker candidates for non-small-cell lung cancer using a targeted Proteomics approach. Journal of Proteome Research, 14(3), 1412-1419. https://doi.org/10.1021/pr5010828
Klingelhutz, A. J., & Roman, A. (2012). Cellular transformation by human papillomaviruses: Lessons learned by comparing high- and low-risk viruses. Virology, 424(2), 77-98. https://doi.org/10.1016/j.virol.2011.12.018
Koike, K. (2013). The oncogenic role of hepatitis C virus. Recent Results in Cancer Research, 97-111. https://doi.org/10.1007/978-3-642-38965-8_6
Kori, M., & Arga, K. Y. (2022). Human oncogenic viruses: An overview of protein biomarkers in viral cancers and their potential use in clinics. Expert Review of Anticancer Therapy, 22(11), 1211-1224. https://doi.org/10.1080/14737140.2022.2139681
Küppers, R. (2003). B cells under influence: Transformation of B cells by Epstein–Barr virus. Nature Reviews Immunology, 3(10), 801-812. https://doi.org/10.1038/nri1201
Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P. M., Klein, G., Kurilla, M. G., & Masucci, M. G. (1995). Inhibition of antigen processing by the internal repeat region of the Epstein–Barr virus nuclear antigen-1. Nature, 375(6533), 685-688. https://doi.org/10.1038/375685a0
Liang, J., Mittal, K. R., Wei, J. J., Yee, H., Chiriboga, L., & Shukla, P. (2007). Utility of p16INK4a, CEA, Ki67, P53 and ER/PR in the differential diagnosis of benign, Premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for Endocervical glandular lesions. International Journal of Gynecological Pathology, 26(1), 71-75. https://doi.org/10.1097/01.pgp.0000225851.97739.9f
Liloglou, T., Bediaga, N. G., Brown, B. R., Field, J. K., & Davies, M. P. (2014). Epigenetic biomarkers in lung cancer. Cancer Letters, 342(2), 200-212. https://doi.org/10.1016/j.canlet.2012.04.018
Ma, G., Yasunaga, J., & Matsuoka, M. (2016). Multifaceted functions and roles of HBZ in HTLV-1 pathogenesis. Retrovirology, 13(1). https://doi.org/10.1186/s12977-016-0249-x
Ma, G., Yasunaga, J., Fan, J., Yanagawa, S., & Matsuoka, M. (2012). HTLV-1 bZIP factor dysregulates the Wnt pathways to support proliferation and migration of adult T-cell leukemia cells. Oncogene, 32(36), 4222-4230. https://doi.org/10.1038/onc.2012.450
Manoharan, S., & Sathish. (2020). Early diagnosis of lung cancer with probability of malignancy calculation and automatic segmentation of lung CT scan images. Journal of Innovative Image Processing, 2(4), 175-186. https://doi.org/10.36548/jiip.2020.4.002
Mao, Y., Yang, H., Xu, H., Lu, X., Sang, X., Du, S., Zhao, H., Chen, W., Xu, Y., Chi, T., Yang, Z., Cai, J., Li, H., Chen, J., Zhong, S., Mohanti, S. R., Lopez-Soler, R., Millis, J. M., Huang, J., … Zhang, H. (2010). Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma. Gut, 59(12), 1687-1693. https://doi.org/10.1136/gut.2010.214916
Marriott, S. J., & Semmes, O. J. (2005). Impact of HTLV-I tax on cell cycle progression and the cellular DNA damage repair response. Oncogene, 24(39), 5986-5995. https://doi.org/10.1038/sj.onc.1208976
Massie, C. E., & Mills, I. G. (2009). Chromatin Immunoprecipitation (Chip) methodology and Readouts. Methods in Molecular Biology, 123-137. https://doi.org/10.1007/978-1-60327-575-0_7
Masucci, M. G. (2004). Epstein–Barr virus oncogenesis and the ubiquitin–proteasome system. Oncogene, 23(11), 2107-2115. https://doi.org/10.1038/sj.onc.1207372
Matsuoka, M., & Jeang, K. (2010). Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: Viral infectivity, tax, HBZ and therapy. Oncogene, 30(12), 1379-1389. https://doi.org/10.1038/onc.2010.537
Mattick, J. S., & Makunin, I. V. (2005). Small regulatory RNAs in mammals. Human Molecular Genetics, 14(suppl_1), R121-R132. https://doi.org/10.1093/hmg/ddi101
Meijer, C. J., Berkhof, J., Castle, P. E., Hesselink, A. T., Franco, E. L., Ronco, G., Arbyn, M., Bosch, F. X., Cuzick, J., Dillner, J., Heideman, D. A., & Snijders, P. J. (2008). Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. International Journal of Cancer, 124(3), 516-520. https://doi.org/10.1002/ijc.24010
Mesri, E. A. (1999). Inflammatory reactivation and Angiogenicity of Kaposi’s sarcoma-associated Herpesvirus/HHV8: A missing link in the pathogenesis of acquired immunodeficiency syndrome-associated Kaposi’s sarcoma. Blood, 93(12), 4031-4033. https://doi.org/10.1182/blood.v93.12.4031
Mesri, E., Feitelson, M. A., & Munger, K. (2014). Human viral oncogenesis: A cancer hallmarks analysis. Cell Host & Microbe, 15(3), 266-282. https://doi.org/10.1016/j.chom.2014.02.011
Middeldorp, J., & Pegtel, D. (2008). Multiple roles of LMP1 in Epstein-Barr virus induced immune escape. Seminars in Cancer Biology, 18(6), 388-396. https://doi.org/10.1016/j.semcancer.2008.10.004
Mittal, S., & Banks, L. (2017). Molecular mechanisms underlying human papillomavirus E6 and E7 oncoprotein-induced cell transformation. Mutation Research/Reviews in Mutation Research, 772, 23-35. https://doi.org/10.1016/j.mrrev.2016.08.001
Moses, A. V., Fish, K. N., Ruhl, R., Smith, P. P., Strussenberg, J. G., Zhu, L., Chandran, B., & Nelson, J. A. (1999). Long-term infection and transformation of dermal Microvascular endothelial cells by human Herpesvirus 8. Journal of Virology, 73(8), 6892-6902. https://doi.org/10.1128/jvi.73.8.6892-6902.1999
Mulherkar, T. H., Gómez, D. J., Sandel, G., & Jain, P. (2022). Co-infection and cancer: Host–pathogen interaction between dendritic cells and HIV-1, HTLV-1, and other oncogenic viruses. Viruses, 14(9), 2037. https://doi.org/10.3390/v14092037
Murphy, N., Ring, M., Heffron, C. C., Martin, C. M., McGuinness, E., Sheils, O., & O'Leary, J. J. (2005). Quantitation of CDC6 and MCM5 mRNA in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix. Modern Pathology, 18(6), 844-849. https://doi.org/10.1038/modpathol.3800361
Naraki, T., Kohno, N., Saito, H., Fujimoto, Y., Ohhira, M., Morita, T., & Kohgo, Y. (2002). γ-carboxyglutamic acid content of hepatocellular carcinoma-associated des-γ-carboxy prothrombin. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1586(3), 287-298. https://doi.org/10.1016/s0925-4439(01)00107-7
Nooreldeen, R., & Bach, H. (2021). Current and future development in lung cancer diagnosis. International Journal of Molecular Sciences, 22(16), 8661. https://doi.org/10.3390/ijms22168661
Oshlack, A., Robinson, M. D., & Young, M. D. (2010). From RNA-SEQ reads to differential expression results. Genome Biology, 11(12), 220. https://doi.org/10.1186/gb-2010-11-12-220
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., Naoki, K., Sasaki, H., Fujii, Y., Eck, M. J., Sellers, W. R., Johnson, B. E., & Meyerson, M. (2004). EGFR mutations in lung cancer: Correlation with clinical response to Gefitinib therapy. Science, 304(5676), 1497-1500. https://doi.org/10.1126/science.1099314
Parkin, D., Bray, F., & Devesa, S. (2001). Cancer burden in the year 2000. The global picture. European Journal of Cancer, 37, 4-66. https://doi.org/10.1016/s0959-8049(01)00267-2
Pfeffer, S., Zavolan, M., Grässer, F. A., Chien, M., Russo, J. J., Ju, J., John, B., Enright, A. J., Marks, D., Sander, C., & Tuschl, T. (2004). Identification of virus-encoded MicroRNAs. Science, 304(5671), 734-736. https://doi.org/10.1126/science.1096781
Plummer, M., De Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016). Global burden of cancers attributable to infections in 2012: A synthetic analysis. The Lancet Global Health, 4(9), e609-e616. https://doi.org/10.1016/s2214-109x(16)30143-7
Pozzan, C., Cardin, R., Piciocchi, M., Cazzagon, N., Maddalo, G., Vanin, V., Giacomin, A., Pontisso, P., Cillo, U., & Farinati, F. (2014). Diagnostic and prognostic role of SCCA‐IgM serum levels in hepatocellular carcinoma (HCC). Journal of Gastroenterology and Hepatology, 29(8), 1637-1644. https://doi.org/10.1111/jgh.12576
Pu, D., Yin, L., Zhou, Y., Li, W., Huang, L., Cai, L., & Zhou, Q. (2020). Safety and efficacy of immune checkpoint inhibitors in patients with HBV/HCV infection and advanced-stage cancer. Medicine, 99(5), e19013. https://doi.org/10.1097/md.0000000000019013
Qiu, J., Cosmopoulos, K., Pegtel, M., Hopmans, E., Murray, P., Middeldorp, J., Shapiro, M., & Thorley-Lawson, D. A. (2011). A novel persistence associated EBV miRNA expression profile is disrupted in Neoplasia. PLoS Pathogens, 7(8), e1002193. https://doi.org/10.1371/journal.ppat.1002193
Ressing, M. E., Horst, D., Griffin, B. D., Tellam, J., Zuo, J., Khanna, R., Rowe, M., & Wiertz, E. J. (2008). Epstein-Barr virus evasion of CD8+ and CD4+ T cell immunity via concerted actions of multiple gene products. Seminars in Cancer Biology, 18(6), 397-408. https://doi.org/10.1016/j.semcancer.2008.10.008
Rodenhuis, S., Van de Wetering, M. L., Mooi, W. J., Evers, S. G., Van Zandwijk, N., & Bos, J. L. (1987). Mutational activation of the K-rasoncogene. New England Journal of Medicine, 317(15), 929-935. https://doi.org/10.1056/nejm198710083171504
Sandoval, J., Mendez-Gonzalez, J., Nadal, E., Chen, G., Carmona, F. J., Sayols, S., Moran, S., Heyn, H., Vizoso, M., Gomez, A., Sanchez-Cespedes, M., Assenov, Y., Müller, F., Bock, C., Taron, M., Mora, J., Muscarella, L. A., Liloglou, T., Davies, M., … Esteller, M. (2013). A prognostic DNA methylation signature for stage I non–small-cell lung cancer. Journal of Clinical Oncology, 31(32), 4140-4147. https://doi.org/10.1200/jco.2012.48.5516
Schalper, K. A., Brown, J., Carvajal-Hausdorf, D., McLaughlin, J., Velcheti, V., Syrigos, K. N., Herbst, R. S., & Rimm, D. L. (2015). Objective measurement and clinical significance of TILs in non–small cell lung cancer. JNCI: Journal of the National Cancer Institute, 107(3). https://doi.org/10.1093/jnci/dju435
Schiffman, M., Wentzensen, N., Wacholder, S., Kinney, W., Gage, J. C., & Castle, P. E. (2011). Human papillomavirus testing in the prevention of cervical cancer. JNCI: Journal of the National Cancer Institute, 103(5), 368-383. https://doi.org/10.1093/jnci/djq562
Schweizer, J., Lu, P. S., Mahoney, C. W., Berard-Bergery, M., Ho, M., Ramasamy, V., Silver, J. E., Bisht, A., Labiad, Y., Peck, R. B., Lim, J., Jeronimo, J., Howard, R., Gravitt, P. E., & Castle, P. E. (2010). Feasibility study of a human papillomavirus E6 Oncoprotein test for diagnosis of cervical Precancer and cancer. Journal of Clinical Microbiology, 48(12), 4646-4648. https://doi.org/10.1128/jcm.01315-10
Shinjo, K., Okamoto, Y., An, B., Yokoyama, T., Takeuchi, I., Fujii, M., Osada, H., Usami, N., Hasegawa, Y., Ito, H., Hida, T., Fujimoto, N., Kishimoto, T., Sekido, Y., & Kondo, Y. (2012). Integrated analysis of genetic and epigenetic alterations reveals CPG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma. Carcinogenesis, 33(7), 1277-1285. https://doi.org/10.1093/carcin/bgs154
Siddiqui, M. T., Cohen, C., & Nassar, A. (2008). Detecting high-grade cervical disease on ASC-H cytology. American Journal of Clinical Pathology, 130(5), 765-770. https://doi.org/10.1309/ajcpww6v2kgxodui
Sivakumar, R., Sharma-Walia, N., Raghu, H., Veettil, M. V., Sadagopan, S., Bottero, V., Varga, L., Levine, R., & Chandran, B. (2008). Kaposi's sarcoma-associated Herpesvirus induces sustained levels of vascular endothelial growth factors a and C early during in vitro infection of human Microvascular dermal endothelial cells: Biological implications. Journal of Virology, 82(4), 1759-1776. https://doi.org/10.1128/jvi.00873-07
Spangenberg, H., Thimme, R., & Blum, H. (2006). Serum markers of hepatocellular carcinoma. Seminars in Liver Disease, 26(4), 385-390. https://doi.org/10.1055/s-2006-951606
Staskus, K. A., Zhong, W., Gebhard, K., Herndier, B., Wang, H., Renne, R., Beneke, J., Pudney, J., Anderson, D. J., Ganem, D., & Haase, A. T. (1997). Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. Journal of Virology, 71(1), 715-719. https://doi.org/10.1128/jvi.71.1.715-719.1997
Sugauchi, F., Kumada, H., Acharya, S. A., Shrestha, S. M., Gamutan, M. T., Khan, M., Gish, R. G., Tanaka, Y., Kato, T., Orito, E., Ueda, R., Miyakawa, Y., & Mizokami, M. (2004). Epidemiological and sequence differences between two subtypes (AE and AA) of hepatitis B virus genotype a. Journal of General Virology, 85(4), 811-820. https://doi.org/10.1099/vir.0.79811-0
Sun, S., & Ballard, D. W. (1999). Persistent activation of NF-κb by the tax transforming protein of HTLV-1: Hijacking cellular IκB kinases. Oncogene, 18(49), 6948-6958. https://doi.org/10.1038/sj.onc.1203220
Tanaka-Nakanishi, A., Yasunaga, J., Takai, K., & Matsuoka, M. (2014). HTLV-1 bZIP factor suppresses Apoptosis by attenuating the function of FoxO3a and altering its localization. Cancer Research, 74(1), 188-200. https://doi.org/10.1158/0008-5472.can-13-0436
Tatarinov, I. S. (1964). Detection of embryo-specific alpha-globulin in the blood serum of a patient with primary liver cancer. Voprosy meditsinskoi khimii, 10, 90-91.
Tedeschi, R., Marus, A., Bidoli, E., Simonelli, C., & De Paoli, P. (2008). Human herpesvirus 8 DNA quantification in matched plasma and PBMCs samples of patients with HHV8-related lymphoproliferative diseases. Journal of Clinical Virology, 43(3), 255-259. https://doi.org/10.1016/j.jcv.2008.07.005.
Tian, T., Song, C., Jiang, L., Dai, J., Lin, Y., Xu, X., Yu, C., Ge, Z., Ding, Y., Wen, Y., Liu, B., Shao, Y., Shi, P., Zhu, C., Liu, Y., Jing, S., Wang, Z., Hu, Z., & Li, J. (2020). Hepatitis B virus infection and the risk of cancer among the Chinese population. International Journal of Cancer, 147(11), 3075-3084. https://doi.org/10.1002/ijc.33130
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016). Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy. Nature Reviews Cancer, 16(5), 275-287. https://doi.org/10.1038/nrc.2016.36
Tosato, G., Straus, S., Henle, W., Pike, S. E., & Blaese, R. M. (1985). Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). The Journal of Immunology, 134(5), 3082-3088. https://doi.org/10.4049/jimmunol.134.5.3082
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., ... & Yankelewitz, D. (2011). International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. Journal of thoracic oncology, 6(2), 244-285.
Vallée, A., Le Loupp, A., & Denis, M. G. (2014). Efficiency of the Therascreen® RGQ PCR kit for the detection of EGFR mutations in non-small cell lung carcinomas. Clinica Chimica Acta, 429, 8-11. https://doi.org/10.1016/j.cca.2013.11.014.
Vande Pol, S. B., & Klingelhutz, A. J. (2013). Papillomavirus E6 oncoproteins. Virology, 445(1-2), 115-137. https://doi.org/10.1016/j.virol.2013.04.026
Vargas, A. J., & Harris, C. C. (2016). Biomarker development in the precision medicine era: Lung cancer as a case study. Nature Reviews Cancer, 16(8), 525-537. https://doi.org/10.1038/nrc.2016.56
Vernin, C., Thenoz, M., Pinatel, C., Gessain, A., Gout, O., Delfau-Larue, M., Nazaret, N., Legras-Lachuer, C., Wattel, E., & Mortreux, F. (2014). HTLV-1 bZIP factor HBZ promotes cell proliferation and genetic instability by activating OncomiRs. Cancer Research, 74(21), 6082-6093. https://doi.org/10.1158/0008-5472.can-13-3564
Viens, L. J., Henley, S. J., Watson, M., Markowitz, L. E., Thomas, C. C., Thompson, T. D., Razzaghi, H., & Saraiya, M. (2016). Human papillomavirus–associated cancers — United States, 2008–2012. MMWR. Morbidity and Mortality Weekly Report, 65(26), 661-666. https://doi.org/10.15585/mmwr.mm6526a1
Visvanathan, K., & Lewin, S. (2006). Immunopathogenesis: Role of innate and adaptive immune responses. Seminars in Liver Disease, 26(2), 104-115. https://doi.org/10.1055/s-2006-939755
Volk, M. L., Hernandez, J. C., Su, G. L., Lok, A. S., & Marrero, J. A. (2007). Risk factors for hepatocellular carcinoma may impair the performance of biomarkers: A comparison of AFP, DCP, and AFP-L31. Cancer Biomarkers, 3(2), 79-87. https://doi.org/10.3233/cbm-2007-3202
Wang, H., Trotter, M. W., Lagos, D., Bourboulia, D., Henderson, S., Mäkinen, T., Elliman, S., Flanagan, A. M., Alitalo, K., & Boshoff, C. (2004). Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nature Genetics, 36(7), 687-693. https://doi.org/10.1038/ng1384
Wang, J. W., & Roden, R. B. (2013). L2, the minor capsid protein of papillomavirus. Virology, 445(1-2), 175-186. https://doi.org/10.1016/j.virol.2013.04.017
Wentzensen, N., & Von Knebel Doeberitz, M. (2007). Biomarkers in cervical cancer screening. Disease Markers, 23(4), 315-330. https://doi.org/10.1155/2007/678793
Whitby, D., Boshoff, C., Hatzioannou, T., Weiss, R., Schulz, T., Howard, M., Brink, N., Tedder, R., Tenant-Flowers, M., Copas, A., Suggett, F., Aldam, D., Denton, A., Miller, R., & Weller, I. (1995). Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. The Lancet, 346(8978), 799-802. https://doi.org/10.1016/s0140-6736(95)91619-9
Williams, H., & Crawford, D. H. (2006). Epstein-Barr virus: The impact of scientific advances on clinical practice. Blood, 107(3), 862-869. https://doi.org/10.1182/blood-2005-07-2702
Wishart, D. S. (2016). Emerging applications of metabolomics in drug discovery and precision medicine. Nature Reviews Drug Discovery, 15(7), 473-484. https://doi.org/10.1038/nrd.2016.32.
Wong, Y., Meehan, M. T., Burrows, S. R., Doolan, D. L., & Miles, J. J. (2021). Estimating the global burden of Epstein–Barr virus-related cancers. Journal of Cancer Research and Clinical Oncology, 148(1), 31-46. https://doi.org/10.1007/s00432-021-03824-y
Yanagisawa, K., Shyr, Y., Xu, B. J., Massion, P. P., Larsen, P. H., White, B. C., Roberts, J. R., Edgerton, M., Gonzalez, A., Nadaf, S., Moore, J. H., Caprioli, R. M., & Carbone, D. P. (2003). Proteomic patterns of tumour subsets in non-small-cell lung cancer. The Lancet, 362(9382), 433-439. https://doi.org/10.1016/s0140-6736(03)14068-8
Ye, F., Blackbourn, D. J., Mengel, M., Xie, J., Qian, L., Greene, W., Yeh, I., Graham, D., & Gao, S. (2007). Kaposi's sarcoma-associated Herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1. Journal of Virology, 81(8), 3980-3991. https://doi.org/10.1128/jvi.02089-06
Young, L. S., & Murray, P. G. (2003). Epstein–Barr virus and oncogenesis: From latent genes to tumours. Oncogene, 22(33), 5108-5121. https://doi.org/10.1038/sj.onc.1206556
Young, L. S., & Rickinson, A. B. (2004). Epstein–Barr virus: 40 years on. Nature Reviews Cancer, 4(10), 757-768. https://doi.org/10.1038/nrc1452
Yu, L., Wang, L., Zhong, J., & Chen, S. (2010). Diagnostic value of p16INK4A, Ki‐67, and human papillomavirus L1 capsid protein immunochemical staining on cell blocks from residual liquid‐based gynecologic cytology specimens. Cancer Cytopathology, 118(1), 47-55. https://doi.org/10.1002/cncy.20061
Zeng, W., Li, Y., Fei, H., Cheng, X., Ye, F., Lü, W., & Xie, X. (2011). The value of p16ink4a expression by fluorescence in situ hybridization in triage for high risk HPV positive in cervical cancer screening. Gynecologic Oncology, 120(1), 84-88. https://doi.org/10.1016/j.ygyno.2010.09.008
Zhao, T., Coutts, A., Xu, L., Yu, J., Ohshima, K., & Matsuoka, M. (2013). HTLV-1 bZIP factor supports proliferation of adult T cell leukemia cells through suppression of C/EBPα signaling. Retrovirology, 10(1). https://doi.org/10.1186/1742-4690-10-159
Zou, J., & Wang, E. (2020). Cancer biomarker discovery for precision medicine: New progress. Current Medicinal Chemistry, 26(42), 7655-7671. https://doi.org/10.2174/0929867325666180718164712
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
